A team of researchers at The University of Texas MD Anderson Cancer Center (TX, USA) have discovered a link between the use of neurofeedback and a decrease in personal experience of chronic pain in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN). The results help to expand knowledge of neuropathic pain and a chemotherapy side effect that […]
Genetic testing can help doctors identify the causes of hereditary and idiopathic neuropathies. Genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test can confirm or rule out a suspected genetic condition or help determine a person’s chance of developing or passing on […]
On December 3, 2015, Astellas Pharma US, Inc. (the U.S. affiliate of Astellas Pharma Inc.), a R&D-driven global pharmaceutical company, invited the Foundation for Peripheral Neuropathy to present to a global team working on development of ASP3662 for patients with neuropathic pain (NP). This was an internal meeting, which included Ulf Tollemar, Executive Director, Development […]
Flu season is upon us. At this time of year the Foundation frequently receives inquiries about the safety of getting the flu vaccine if a patient has peripheral neuropathy – especially peripheral neuropathy patients with underlying immune issues. **This information is intended for general educational purposes only. Any decisions regarding vaccinations should be made in […]
Neuropathy is a common side effect of certain medications, especially those used in chemotherapy to fight cancer like cisplatin, carboplatin, and oxaliplatin. While symptoms might disappear over time, for some the shooting pain or a loss of feeling in the hands and feet may become chronic. A recent study investigated the effects of Botox B, […]
Read More… from Nerve Pain Therapy: Botox May Treat Peripheral Neuropathy in Cancer Patients
Scientists at Washington University School of Medicine in St. Louis, reported new research that highlights how nerves – whether harmed by disease or traumatic injury – start to die, a discovery that unveils novel targets for developing drugs to slow or halt peripheral neuropathies and devastating neurodegenerative disorders such as…READ MORE Source: News Medical […]
Read More… from Discovery Unveils Novel Drug Targets to Halt Peripheral Neuropathies…
With more than 26 million people in the US living with diabetes, as reported by the Centers for Disease Control, approximately 60-70% of them will develop nerve damage called neuropathy at some point. New research has been published indicating that patients suffering with diabetic peripheral neuropathy (DPN) may experience a significant improvement in their pain […]
A recent article links some nerve damage after hip surgery to inflammatory neuropathy. In this study, researchers examined patients who developed inflammatory neuropathies, where the immune system attacks the nerves, leading to weakness and pain. READ MORE Source: ScienceDaily […]
Read More… from Nerve Damage After Hip Surgery May Be Due to Inflammation
If you have diabetic nerve pain in your feet, legs, arms, or hands, consider this: research published in The Journal of Diabetes Complications showed significant benefits of exercise in controlling peripheral neuropathy. The study showed that for people who took a brisk, one-hour walk on a treadmill four times a week, exercise slowed how quickly their nerve […]
Read More… from Managing Diabetes with Exercise: 6 Tips for Nerve Pain
Peripheral neuropathy presents clinically in 30–60% of people living with human immunodeficiency virus (HIV), and nearly all AIDS patients have an evidence of peripheral neuropathy at autopsy. HIV-associated sensory neuropathy (HIV-SN) is one of the most common forms of peripheral neuropathy. It has been found that 57% of HIV-infected individuals have distal symmetrical SN and […]